
243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection
The Readout Loud
00:00
Introduction
This week's episode of The Readout Loud is a weekly biotech podcast from STAT. We'll kick things off with some takes on this week's news, including an FDA advisory meeting on COVID vaccines and a surprising, but perhaps not surprising, rejection of an Alzheimer's disease drug. George Gengos, the CEO of VIR Biotechnology, announced his retirement this week, closing out a remarkable 40-year career in biotech.
Transcript
Play full episode